Series A Life Science Companies

Petragen is a biotechnology company spun out of Yale University and the NIH focused on novel therapies for periodontal disease

The Only AI-Powered Analytics Platform Purpose-Built for Life Sciences and Healthcare

anvajo GmbH is a Dresden-based technology company that develops, manufactures and sells innovative solutions for the analysis of liquids.

Empyrean is using genetic engineering to treat severe neuropsychiatric and neurologic illnesses in a way that will revolutionize healthcare.

Obatala Sciences is an assay and research tool development tissue-chip company that specializes in fat-chips.

We create sustainable cultivated meat delights for an uncompromising and conscious generation.

Epion is developing a minimally invasive treatment for an ectatic corneal disease.

Form Bio is a platform for data management, workflows, and data visualisation.

Elucidata delivers ML-ready biomedical molecular data that is curated to accelerate drug discovery.

Lixa develops revolutionary, scalable solutions for antimicrobial resistance (AMR) and the US$5T per annum biofilm problem.

Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics.

Ganymede is a low-code PaaS for biotech software engineering that enables users to connect apps, ingest data, and construct pipelines.

Syntr Health Technologies develops and tests a processing device for the micro fragmentation of adipose tissue for body contouring.

Ozette Technologies is a life science data company that accelerates the development of therapies and diagnostics by digitizing immune data.

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives.

Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.

DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.

Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.

Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.

MycoMedica Life Sciences, PBC develops fungi-based therapeutic drugs for psychiatric and neurological disorders.

Enumera Molecular is developing a scalable biomolecule assessment platform enabling lower-cost, rapid clinical liquid biopsy tests.

Pheast Therapeutics develops checkpoint therapies to harness the innate immune system.

Proof Diagnostics is a health technology company that develops a diagnostic test for the detection of coronavirus disease infection.

RNAimmune is a biopharmaceutical company specializing in the discovery and development of mRNA-based therapeutics and vaccines.

InnoSIGN is a manufacturer of precision medicine for diagnostics and drug development applications.